Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
1.320
+0.060 (4.76%)
At close: Apr 2, 2025, 4:00 PM
1.260
-0.060 (-4.55%)
After-hours: Apr 2, 2025, 6:34 PM EDT

Galectin Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-47.05-41.07-38.78-30.53-23.47
Upgrade
Depreciation & Amortization
0.040.030.030.040.04
Upgrade
Stock-Based Compensation
2.452.262.872.081.8
Upgrade
Other Operating Activities
0.511.13-0.150.150.09
Upgrade
Change in Accounts Payable
-2.072.674.243.692.54
Upgrade
Change in Other Net Operating Assets
4.362.010.720.27-1.59
Upgrade
Operating Cash Flow
-41.77-32.97-31.06-24.31-20.6
Upgrade
Long-Term Debt Issued
30301030-
Upgrade
Net Debt Issued (Repaid)
30301030-
Upgrade
Issuance of Common Stock
1.2310.03-6.810.26
Upgrade
Financing Cash Flow
31.2340.031036.810.26
Upgrade
Net Cash Flow
-10.547.07-21.0612.51-20.34
Upgrade
Levered Free Cash Flow
-28.94-20.68-17.56-13.23-11.89
Upgrade
Unlevered Free Cash Flow
-25.48-18.93-16.91-12.92-11.84
Upgrade
Change in Net Working Capital
1.44-2.57-4.16-3.82-0.98
Upgrade
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q